Lightnews — Scholar-powered news

Reposted by Benyam Muluneh, PharmD, BCOP

isopporg.bsky.social @isopporg.bsky.social · Jul 8

🚨 1 in 6 cancer meds in sub-Saharan Africa failed quality tests. ISOPP & UICC urge global action to ensure safe, effective treatment. “This highlights supply chain vulnerabilities,” says Dr Benyam Muluneh. 🔗 Full statement www.isopp.org/article/isop... #CancerCare #MedicineSafety #GlobalHealthEquity

1 1 1

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Jun 26

Check out our latest article on @lancetgh.bsky.social

🚩 1 in 6 chemotherapy products tested in LMIC settings failed assay🚩

This work was possible thanks to funding from @NIH & our in-country PIs. Thank you Dr. Marya Lieberman for your amazing leadership!

www.thelancet.com/journals/lan...

Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation

Oncology practitioners and health systems in sub-Saharan Africa need to be aware of the possible presence of substandard anticancer products when designing care protocols and evaluating patient outcom...

www.thelancet.com

1 2 4

Reposted by Benyam Muluneh, PharmD, BCOP

New York Times Opinion @nytopinion.nytimes.com · Feb 12

"U.S.A.I.D. employees, who mostly joined the agency in hopes of making the world a better place, are in agony," our columnist @nickkristof.bsky.social writes. "'We're just paralyzed,' an agency employee in Africa told me. 'No one is in charge.'"

Opinion | It’s America That Suffers When We Cut Foreign Aid

U.S.A.I.D. keeps children alive and us safe.

www.nytimes.com

14 84 310

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Feb 11

youtube.com/watch?v=VuqH...

youtube.com

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Feb 11

“Oddly silent.”

Jeremy C. Young @jeremycyoung.bsky.social · Feb 11

Some higher ed organizations who are loudly circling the wagons against federal funding cuts were oddly silent or circumspect about the earlier attacks on CRT and DEI.

I wish there was a better understanding that these attacks are coming because we failed to repel those.

Reposted by Benyam Muluneh, PharmD, BCOP

Ryan Marino, MD @ryanmarino.bsky.social · Feb 10

Hospitals that can afford Super Bowl ads shouldn’t be sending their patients to collections

Karen “the good kind” @kpsinging.bsky.social · Feb 10

So what do my HCW friends think about NYU Langone spending millions of dollars in the Super Bowl for an ad instead of say paying more to their workers or buy new equipment?
Good use of resources? 🤔

65 1.4K 7.1K

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Feb 8

🚨

Peter Gleick @petergleick.bsky.social · Feb 8

Here's a lesson for all of us that the universities are relearning today:
Staying silent in the face of fascism will not protect you.

Reposted by Benyam Muluneh, PharmD, BCOP

Daddy Chill @xdaddychill.bsky.social · Feb 5

If you oppose DEI you should have to use the full phrase, “I oppose diversity, equity and inclusion.”

Bonus points if you add your points, “I oppose disabled veterans equal access to employment.” “I oppose mothers having jobs.”

Making it an acronym turns it into a thought-terminating cliche.

50 800 2.9K

Reposted by Benyam Muluneh, PharmD, BCOP

Darby Saxbe @darbysaxbe.bsky.social · Feb 4

🚨BREAKING. From a program officer at the National Science Foundation, a list of keywords that can cause a grant to be pulled. I will be sharing screenshots of these keywords along with a decision tree. Please share widely. This is a crisis for academic freedom & science.

1.3K 16K 28K

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Jan 31

This.

jamelle @jamellebouie.net · Jan 30

i think it is important to say that the open and explicit racism of the president and the vice president isn’t just uncouth or “controversial” but a direct attack on tens of millions of americans and a dereliction of their duty to represent the entire country

1 1

Reposted by Benyam Muluneh, PharmD, BCOP

BK. Titanji @boghuma.bsky.social · Jan 30

As we watch all mention of diversity actively get scrubbed from the NIH website in real time it's important to know that, we were not taking over anything, we were just trying to exist.
- Only 2% of NIH R01 grants are awarded to Black investigators.
The goal is total erasure/elimination.

20 270 870

Reposted by Benyam Muluneh, PharmD, BCOP

Patrick Hickey, MD @pwhickey.bsky.social · Dec 17

There’s no reason that we can’t have federal health leadership that wants children to have both healthy food & vaccines. They aren’t mutually exclusive 🧐

4 8 50

Reposted by Benyam Muluneh, PharmD, BCOP

Adam Grant @adamgrant.bsky.social · Dec 15

Writing isn't what you do after you have an idea. It's how you develop an inkling into an insight.

Turning thoughts into words sharpens reasoning. What's fuzzy in your head is clear on the page.

"I'm not a writer" shouldn't stop you from writing. Writing is a tool for thinking.

7 57 280

Reposted by Benyam Muluneh, PharmD, BCOP

Shematologist, MD @shematologist.medsky.social · Dec 8

Staggering statistics at #ASH24 #TreatingFairly

Patients with cancer who go bankrupt are nearly 80% more likely to die regardless of disease status.

Our system quite literally kills people.

Slide on financial toxicity of cancer care

22 200 520

Reposted by Benyam Muluneh, PharmD, BCOP

Arrianna Marie Planey, PhD MA @arrianna-planey.bsky.social · Nov 22

Finally out- our study of travel burdens and health system factors and rural-dwelling adults' breast, cervical, and colorectal cancer screening receipt link.springer.com/article/10.1...

Longer travel times to acute hospitals are associated with lower likelihood of cancer screening receipt among rural-dwelling adults in the U.S. South - Cancer Causes & Control

Purpose Given rural hospitals’ role in providing outpatient services, we examined the association between travel burdens and receipt of cancer screening among rural-dwelling adults in the U.S. South r...

link.springer.com

3 26 60

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 21

Excited to present all the hard work of my spectacular team at #ESPACOMP24

Thankful for the #NIH for funding this work.

💊We now understand the gaps and solutions offered by patients with cancer
💡Next, we will be developing an intervention to support patients on oral oncolytics.

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 21

Non-adherence in cancer continues to be a major gap.
#ESPACOMP24

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 21

ABC Taxonomy on the phases of #adherence

#ESPACOMP24

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 21

US Audience member: does cost matter for these patients in impacting #adherence?

European presenter: no, cost doesn’t matter.

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 21

Implementation Science 🤝 Adherence intervention development

1

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 21

Excited to be at my first in-person #ESPACOMP (International Society for Med Adherence) conference.

Reposted by Benyam Muluneh, PharmD, BCOP

Shematologist, MD @shematologist.medsky.social · Nov 20

Europeans: Thanks for your email. I’m on vacation so as you read this response, the email you sent is disappearing into thin air, never to be read by human eyes.

Americans: My sincerest apologies. The infant I am birthing is currently crowning but not to worry, I will get back to you momentarily.

11 27 370

Benyam Muluneh, PharmD, BCOP @bmuluneh.bsky.social · Nov 19

Their emergency ≠ Your emergency.

DD Wallace, PhD, MSPH @dra-wallace.bsky.social · Nov 19

Daily reminder: it’s ok to ignore those email/requests that come to you with a false sense of urgency.
Ignore it. Don’t let these things ruin your day.

1 1

Reposted by Benyam Muluneh, PharmD, BCOP

Angie Nichols @leuknp.bsky.social · Nov 16

I big step for those of us that fight against AML alongside our amazing patients. The first menin inhibitor gets FDA approval today! Huge congrats to all of those that worked hard to bring this to fruition to allow more options for this terrible disease.

www.fda.gov/drugs/resour...

FDA approves revumenib for relapsed or refractory acute leukemia

On November 15, 2024, the FDA approved revumenib (Revuforj, Syndax Pharmaceuticals, Inc.) for relapsed or refractory acute leukemia with a KMT2A translocation.

www.fda.gov

1 1

Reposted by Benyam Muluneh, PharmD, BCOP

Stacie Dusetzina @dusetzinas.bsky.social · Nov 16

Open enrollment got you in a panic about affording your meds next year? Great tips below to help!

If you are on Medicare, your best bet is to shop for a plan before December 7th. No reason to overpay and most people don't shop! Can make a big difference at the pharmacy counter!

Ben Rome @benro.me · Nov 16

How can clinicians help their patients afford costly medications?? 💊💰

In a recent JAMA review, we outlined an algorithm and talk about the pros and cons of several options, including copay cards, pharmacy coupons, and more.

#Medsky 🩺📊
@portalresearch.bsky.social

jamanetwork.com/journals/jam...

Algorithm for How to Assist Patients With Unaffordable Prescription Drug Costs

1 7 13